Regenxbio Stock Alpha and Beta Analysis
| RGNX Stock | USD 8.24 0.12 1.44% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Regenxbio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Regenxbio over a specified time horizon. Remember, high Regenxbio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Regenxbio's market risk premium analysis include:
Beta (0.01) | Alpha (0.05) | Risk 4.4 | Sharpe Ratio 0.0761 | Expected Return 0.33 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Regenxbio |
Regenxbio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Regenxbio market risk premium is the additional return an investor will receive from holding Regenxbio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Regenxbio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Regenxbio's performance over market.| α | -0.05 | β | -0.0066 |
Regenxbio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Regenxbio's Buy-and-hold return. Our buy-and-hold chart shows how Regenxbio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Regenxbio Market Price Analysis
Market price analysis indicators help investors to evaluate how Regenxbio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regenxbio shares will generate the highest return on investment. By understating and applying Regenxbio stock market price indicators, traders can identify Regenxbio position entry and exit signals to maximize returns.
Regenxbio Return and Market Media
The median price of Regenxbio for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 is 7.51 with a coefficient of variation of 9.82. The daily time series for the period is distributed with a sample standard deviation of 0.73, arithmetic mean of 7.47, and mean deviation of 0.57. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 11395 shares by Christmas Patrick J. of Regenxbio at 7.73 subject to Rule 16b-3 | 01/02/2025 |
2 | Macular Degeneration Treatment Market Size is Projected to Reach USD 18.59 Billion by 2033, Growing at a CAGR of 7.06 percent Straits Research | 01/29/2025 |
3 | JPMorgan Chase Co. Increases Stake in Regenxbio Inc. | 02/12/2025 |
4 | Acquisition by Christmas Patrick J. of 56446 shares of Regenxbio subject to Rule 16b-3 | 02/14/2025 |
5 | Castle Biosciences, Inc. Reports Next Week Wall Street Expects Earnings Growth | 02/20/2025 |
6 | REGENXBIO Upgraded to Hold at StockNews.com | 02/26/2025 |
7 | The Market Doesnt Like What It Sees From REGENXBIO Inc.s Revenues Yet As Shares Tumble 27 | 03/04/2025 |
8 | Jim Cramer on REGENXBIO Inc. This Thing Just Does Nothing But Go Down | 03/06/2025 |
9 | Regenxbio Q4 2024 Earnings Preview | 03/12/2025 |
10 | Regenxbio Reports Q4 Loss, Lags Revenue Estimates | 03/13/2025 |
11 | Q4 2024 Regenxbio Inc Earnings Call Transcript | 03/14/2025 |
About Regenxbio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Regenxbio or other stocks. Alpha measures the amount that position in Regenxbio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | |
| Interest Debt Per Share | 2.74 | 2.2 | 1.91 |
| Revenue Per Share | 2.61 | 2.06 | 1.68 |
Regenxbio Upcoming Company Events
As portrayed in its financial statements, the presentation of Regenxbio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Regenxbio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Regenxbio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Regenxbio. Please utilize our Beneish M Score to check the likelihood of Regenxbio's management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Regenxbio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Regenxbio Stock Analysis
When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.